Kaiming Sun
Impact in
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
- Oncology top 1%
- PARP inhibition in cancer therapy
Papers in
- Oncology 6
- PARP inhibition in cancer therapy 6
-
- Ovarian cancer diagnosis and treatment 2
- Co-authors
- Keith W. Mikule (3 shared papers)Jeffrey H. Hanke (2 shared papers)Sridhar Ramaswamy (2 shared papers)Zebin Wang (2 shared papers)Graham M. Lord (1 shared paper)Richard G. Jenner (1 shared paper)Ian Jackson (1 shared paper)Michael J. Townsend (1 shared paper)
- Journals
- Blood (2 papers)Scientific Reports (1 paper)Oncotarget (1 paper)The Lancet Oncology (1 paper)Molecular and Cellular Biology (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Kaiming Sun
13 papers receiving 4.6k citations
Kaiming Sun's Hit Papers
Peers
Comparison fields: 5 of 105
- Reproductive Medicine 869
- Oncology 2.0k
- Molecular Biology 2.4k
- Cancer Research 379
- Immunology 452
Countries citing papers authored by Kaiming Sun
This map shows the geographic impact of Kaiming Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaiming Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaiming Sun more than expected).
Fields of papers citing papers by Kaiming Sun
This network shows the impact of papers produced by Kaiming Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaiming Sun. The network helps show where Kaiming Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Kaiming Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells Hit paper breakdown → | 2006 | 1837 |
| 2 | Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer Hit paper breakdown → | 2019 | 1689 |
| 3 | Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial Hit paper breakdown → | 2019 | 434 |
| 4 | 2019 | 205 | |
| 5 | 2009 | 196 | |
| 6 | 2018 | 138 | |
| 7 | 2016 | 116 | |
| 8 | 2020 | 22 | |
| 9 | 2006 | 19 | |
| 10 | 2019 | 15 | |
| 11 | 2001 | 4 | |
| 12 | 2015 | 4 | |
| 13 | 2016 | 4 |
About Kaiming Sun
Kaiming Sun is a scholar working on Oncology, Reproductive Medicine, Molecular Biology, Pathology and Forensic Medicine and Genetics, having authored 13 papers that have together received 4.7k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (6 papers), Protein Degradation and Inhibitors (3 papers), Histone Deacetylase Inhibitors Research (3 papers), CRISPR and Genetic Engineering (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Fungal and yeast genetics research (2 papers), Immune Cell Function and Interaction (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Reproductive Medicine (869 citations), Oncology (2.0k citations), Molecular Biology (2.4k citations), Cancer Research (379 citations) and Immunology (452 citations). Kaiming Sun has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Keith W. Mikule, Jeffrey H. Hanke, Sridhar Ramaswamy, Zebin Wang, Graham M. Lord, Richard G. Jenner, Ian Jackson, Michael J. Townsend, Russell D. Bouwman and Richard A. Young. Their work appears in journals such as Blood, Scientific Reports, Oncotarget, The Lancet Oncology and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.